Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics
Overview
Authors
Affiliations
Myocardial infarction (MI) is a complicated pathology triggered by numerous environmental and genetic factors. Understanding the effect of epigenetic regulation mechanisms on the cardiovascular disease would advance the field and promote prophylactic methods targeting epigenetic mechanisms. Genetic screening guides individualised MI therapies and surveillance. The present review reported the latest development on the epigenetic regulation of MI in terms of DNA methylation, histone modifications, and microRNA-dependent MI mechanisms and the novel therapies based on epigenetics.
Yatham P, Jaideep M, Ramadevi V, Pogula A, Periasamy P J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4327-S4330.
PMID: 40061764 PMC: 11888720. DOI: 10.4103/jpbs.jpbs_1129_24.
Targeting KDM4C Prevents Heart Failure after Acute Myocardial Infarction Via Activation of SOS2.
Tan C, Chen X, Xu L, Chen J, Tu Y J Cardiovasc Transl Res. 2025; .
PMID: 39900886 DOI: 10.1007/s12265-025-10594-2.
Guo L, Tripathi H, Gao E, Tarhuni W, Abdel-Latif A Stem Cell Rev Rep. 2024; 20(7):1971-1980.
PMID: 38985374 DOI: 10.1007/s12015-024-10759-7.
Bibliometric and visual analysis of RAN methylation in cardiovascular disease.
Song B, Xie B, Liu M, Li H, Shi D, Zhao F Front Cardiovasc Med. 2023; 10:1110718.
PMID: 37063953 PMC: 10098125. DOI: 10.3389/fcvm.2023.1110718.
Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes?.
Gallego-Fabrega C, Muino E, Carcel-Marquez J, Llucia-Carol L, Lledos M, Martin-Campos J Int J Mol Sci. 2022; 23(12).
PMID: 35743317 PMC: 9224543. DOI: 10.3390/ijms23126840.